Asuragen, Inc.

134 articles about Asuragen, Inc.

• Asuragen, Inc. Signs Development and Worldwide Distribution Agreement with Life Technologies (JOBS)

  11/18/2009

• Asuragen, Inc. Awarded More Than $3.8 Million in New National Institutes of Health (NIH) Small Business Grants

  10/7/2009

• Asuragen, Inc. Signs Agreement with Biogen Idec, Inc. (California) to Pursue Companion Diagnostic Strategy

  7/20/2009

• Agilent Technologies Inc. Appoints Asuragen, Inc. as a Certified Service Provider for its aCGH and miRNA Microarrays

  3/17/2009

• Asuragen, Inc. Initiates Launch of CE-Marked Molecular Diagnostic Products with the Release of the Signature(R) LTx v2.0 Leukemia Translocation Panel Assay in Europe

  12/5/2008

• Asuragen, Inc. Launches a Multiplex qRT-PCR Assay for the Detection of BCR/ABL1 Fusion Transcripts

  12/1/2008

• Applied Biosystems and Asuragen, Inc. Collaborate with the Critical Path Institute to Improve Drug Toxicity Screening

  11/6/2008

• Asuragen, Inc. Adds NuGEN Technologies, Inc. Ovation® Systems to Gene Expression Profiling Menu for RNA Amplification and Target Preparation

  10/22/2008

• Asuragen, Inc. Signs Armored RNA(R) Licensing Agreement with Focus Diagnostics, Inc.

  9/9/2008

• Asuragen, Inc. Launches Signature(R) NPM1 Mutations (RUO)*: A Rapid Multiplex Assay for the Detection of NPM1 Mutations

  8/18/2008

• Affymetrix (Santa Clara, California) and Asuragen, Inc. Sign Agreement to Develop IVT Reagent Kits for Molecular Diagnostic Applications

  7/8/2008

• Asuragen, Inc. to Present Study Results on Differentially Expressed microRNA Biomarkers in Pancreatic FNA and FFPE Specimens at the Annual Meeting of the European Pancreatic Club in Poland

  6/23/2008

• Asuragen, Inc. Launches RNARetain(TM), as a CE-Marked In-Vitro Diagnostic Device

  5/14/2008

• Asuragen, Inc. Launches The First Validated microRNA Diagnostic Assay

  4/23/2008

• Asuragen, Inc. Launches Signature(R) LTx (Leukemia Translocation Panel) Globally

  4/23/2008

• Asuragen, Inc. Launches Mirna Therapeutics

  4/3/2008

• Asuragen, Inc. to Present at the JPMorgan 26th Annual Healthcare Conference

  1/3/2008

• Asuragen, Inc. to Present at the JPMorgan 26th Annual Healthcare Conference

  1/3/2008

• Asuragen, Inc. Introduces Four New microRNA Services

  12/19/2007

• Asuragen, Inc. Raises $18.5 Million in Series B Financing

  12/10/2007